Dextromethorphan Modulates the Osteogenic-Adipogenic Balance in Rat Bone Marrow Mesenchymal Stem Cells

Area of Science:

• Stem cell biology
• Cellular differentiation
• Pharmacology

Background:

• Bone marrow-derived mesenchymal stem cells (BMSCs) are crucial for skeletal homeostasis.
• BMSCs differentiate into either adipocytes (fat cells) or osteoblasts (bone-forming cells).
• Understanding drugs that influence this balance is key for skeletal health.

Purpose of the Study:

• To investigate if dextromethorphan (DXM) influences BMSC differentiation.
• To explore the signaling pathways involved in DXM's effect on lineage commitment.

Main Methods:

• Rat BMSCs were cultured and induced towards adipogenesis or osteogenesis with DXM.
• Adipogenesis and osteogenesis were quantified using Oil Red O and Alizarin Red S staining.
• Gene expression, intracellular calcium, ROS levels, and protein signaling (p-AKT, p-ERK) were analyzed.

Main Results:

• DXM enhanced adipogenesis, increasing lipid accumulation and adipogenic markers (Pparγ, Fabp4).
• DXM promoted intracellular calcium and ROS but these were not responsible for the adipogenic effect.
• DXM inhibited osteogenesis, reducing matrix mineralization and osteogenic markers (Runx2, Bglap).

Conclusions:

• DXM shifts the BMSC differentiation balance towards adipogenesis.
• This effect occurs through a non-canonical mechanism, independent of major signaling pathways typically involved.
• DXM's influence on BMSC fate warrants further investigation for potential therapeutic or adverse skeletal effects.